Yoneda T - Search Results

1

Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.

Hiraga T, Myoui A, Choi ME, Yoshikawa H, Yoneda T. Hiraga T, et al. Among authors: yoneda t. Cancer Res. 2006 Feb 15;66(4):2067-73. doi: 10.1158/0008-5472.CAN-05-2012. Cancer Res. 2006. PMID: 16489006

2

Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.

Hiraga T, Ueda A, Tamura D, Hata K, Ikeda F, Williams PJ, Yoneda T. Hiraga T, et al. Among authors: yoneda t. Int J Cancer. 2003 Oct 10;106(6):973-9. doi: 10.1002/ijc.11330. Int J Cancer. 2003. PMID: 12918079

3

C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.

Myoui A, Nishimura R, Williams PJ, Hiraga T, Tamura D, Michigami T, Mundy GR, Yoneda T. Myoui A, et al. Among authors: yoneda t. Cancer Res. 2003 Aug 15;63(16):5028-33. Cancer Res. 2003. PMID: 12941830

4

Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model.

Hiraga T, Williams PJ, Ueda A, Tamura D, Yoneda T. Hiraga T, et al. Among authors: yoneda t. Clin Cancer Res. 2004 Jul 1;10(13):4559-67. doi: 10.1158/1078-0432.CCR-03-0325. Clin Cancer Res. 2004. PMID: 15240548

5

Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.

Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T. Hiraga T, et al. Among authors: yoneda t. Cancer Res. 2007 May 1;67(9):4157-63. doi: 10.1158/0008-5472.CAN-06-2355. Cancer Res. 2007. PMID: 17483326

6

Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone.

Tamura D, Hiraga T, Myoui A, Yoshikawa H, Yoneda T. Tamura D, et al. Among authors: yoneda t. Int J Oncol. 2008 Jul;33(1):17-24. Int J Oncol. 2008. PMID: 18575746

7

Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases.

Hiraga T, Myoui A, Hashimoto N, Sasaki A, Hata K, Morita Y, Yoshikawa H, Rosen CJ, Mundy GR, Yoneda T. Hiraga T, et al. Among authors: yoneda t. Cancer Res. 2012 Aug 15;72(16):4238-49. doi: 10.1158/0008-5472.CAN-11-3061. Epub 2012 Jun 27. Cancer Res. 2012. PMID: 22738911 Free PMC article.

8

The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.

Hiraga T, Williams PJ, Mundy GR, Yoneda T. Hiraga T, et al. Among authors: yoneda t. Cancer Res. 2001 Jun 1;61(11):4418-24. Cancer Res. 2001. PMID: 11389070

9

The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs.

Michigami T, Hiraga T, Williams PJ, Niewolna M, Nishimura R, Mundy GR, Yoneda T. Michigami T, et al. Among authors: yoneda t. Breast Cancer Res Treat. 2002 Oct;75(3):249-58. doi: 10.1023/a:1019905111666. Breast Cancer Res Treat. 2002. PMID: 12353814

10

A synthetic peptide fragment of human MEPE stimulates new bone formation in vitro and in vivo.

Hayashibara T, Hiraga T, Yi B, Nomizu M, Kumagai Y, Nishimura R, Yoneda T. Hayashibara T, et al. Among authors: yoneda t. J Bone Miner Res. 2004 Mar;19(3):455-62. doi: 10.1359/JBMR.0301263. Epub 2003 Dec 29. J Bone Miner Res. 2004. PMID: 15040834 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,015 results

Search Page

Filters